TITLE

Vaccination Strategies in the Treatment of Lymphomas

AUTHOR(S)
Veelken, Hendrik; Osterroth, Frank
PUB. DATE
April 2002
SOURCE
Oncology;2002, Vol. 62 Issue 3, p187
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Malignant lymphomas are clonal neoplasms of lymphoid origin. By definition, all cells of the malignant clone have undergone the same rearrangement of antigen receptor genes and express identical antigen receptor molecules (immunoglobulin for B cell lymphomas, T cell receptor for T cell lymphomas). The hypervariable stretches within the variable regions of these receptors are considered true tumor-specific antigens (‘idiotypes’). In several animal models, protective humoral or cellular immunity can be induced against the malignant lymphoma by vaccination with the tumor-derived idiotype. Successful experimental immunization strategies in animals include idiotype protein vaccines combined with various adjuvants, genetically or immunologically modified lymphoma cells, idiotype-presenting dendritic cells, idiotype-encoding viral vectors, and DNA immunization. Firm evidence for the induction of lymphoma-specific immunity has also been obtained from human idiotype vaccination trials. Furthermore, some trials have provided strong but hitherto formally unproven evidence for clinical benefit of idiotype-vaccinated patients. Alternative vaccination approaches are based on immunologically modified tumor cells. Current research efforts concentrate on the identification of the most efficacious vaccination route, on definitive proof of clinical efficacy, and on the development of convenient methods to manufacture individual idiotype vaccines.Copyright © 2002 S. Karger AG, Basel
ACCESSION #
11376351

 

Related Articles

  • Prognostic significance of t(14;18) and bcl-2 gene... Martinka, Magda; Comeau, Terry // Clinical & Investigative Medicine;Dec97, Vol. 20 Issue 6, p364 

    Evaluates whether there is an association between the presence of t(14;18) and bcl-2 gene expression in patients with follicular small cleaved cell lymphoma (FSCCL) and diffuse large cell lymphoma (DLCL). Materials and methods used; Clinical stage at diagnosis and t(14;18); Response to...

  • Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes. Baskar, Sivasubramanian; Kobrin, Carol B.; Kwak, Larry W. // Journal of Clinical Investigation;May2004, Vol. 113 Issue 10, p1498 

    The clonotypic surface Ig receptor expressed by malignant B cells,idiotype,is a tumor-specific antigen and an attractive target for active immunotherapy.While Ab's specific for tumor idiotype have been well described in patients with B cell malignancies,the precise antigenic epitopes in human...

  • Development of a Mimotope-Based Vaccine Against CD20 Antigen. Meng Li; Wei Han; Quiyang Zhang; Xiaochang Xue; Zenglu Wang; Yingqi Zhang // Protein & Peptide Letters;Jun2007, Vol. 14 Issue 6, p610 

    CD20, a B-cell-specific protein, is a primary target for immunotherapy of B-cell lymphomas. We used a mimotopes of CD20 to construct vaccines for B-cell-related disorders. The immunogenicity of the vaccines was tested in BALB/c mice. Results of this study suggest that the mimotope may be a...

  • Intravascular Lymphomatosis Presenting as Rapidly Progressive Dementia. Heinrich, Alexander; Vogelgesang, Silke; Kirsch, Michael; Khaw, Alexander V. // European Neurology;2005, Vol. 54 Issue 1, p55 

    Discusses a case of intravascular lymphomatosis presenting as rapidly progressive dementia. Case history; Treatment options.

  • Overexpression of c-myb in Leukaemic and Non-Leukaemic Variants of Cutaneous T-Cell Lymphoma. Poenitz, N.; Simon-Ackermann, J.; Gratchev, A.; Qadoumi, M.; Klemke, C.-D.; Stadler, R.; Kremer, A.; Radenhausen, M.; Henke, U.; Assaf, C.; Utikal, J.; Goerdt, S.; Dippel, E. // Dermatology (10188665);2005, Vol. 211 Issue 2, p84 

    Background: The c-myb oncogene is a transcription factor that regulates proliferation, differentiation and apoptosis of haematopoietic cells and activated T cells by binding to promoter sequences of such genes as c-myc or bcl-2 that are expressed in cutaneous T-cell lymphoma (CTCL). Objective:...

  • Atypical Poorly Differentiated Cutaneous T-Cell Lymphoma with an Angiocentric Growth Pattern Presenting Histologically as Vasculitis. Laetsch, B.; Hofbauer, G.; Kempf, W.; Burg, G.; Dummer, R. // Dermatology (10188665);2005, Vol. 210 Issue 4, p341 

    We report the case of a 41-year-old patient with an aggressive cutaneous T-cell lymphoma (CTCL) initially presenting on histology as lymphocytic vasculitis. On repeated histological examination and by molecular biology work-up, the diagnosis of an unclassifiable CTCL could eventually be...

  • Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index. Nicolaides; Fountzilas; Zoumbos; Skarlos; Kosmidis; Pectasides; Karabelis; Giannakakis; Symeonidis; Papadopoulos; Antoniou; Pavlidis // Oncology;1998, Vol. 55 Issue 5, p405 

    Several clinical prognostic factors have been identified that predict treatment outcome in patients with diffuse large cell lymphomas. An International Non-Hodgkin’s Lymphoma Prognostic Index (IPI) has been recently formulated. We tried to identify the clinical prognostic factors that...

  • non-Hodgkin's lymphoma:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p162 

    A definition of the term non-Hodgkin's lymphoma is presented. It refers to a lymphoma other than Hodgkin's disease. Non-Hodgkin's lymphomas may be classified into nodular or diffuse tumor patterns and by cell type. They can be also be classified into high, intermediate, and low grade malignancy...

  • Nutrients Contributing to One-Carbon Metabolism and Risk of Non-Hodgkin Lymphoma Subtypes. Stella Koutros; Yawei Zhang; Yong Zhu; Susan T. Mayne; Sheila Hoar Zahm; Theodore R. Holford; Brian P. Leaderer; Peter Boyle; Tongzhang Zheng // American Journal of Epidemiology;Feb2008, Vol. 167 Issue 3, p287 

    Because little is known about the etiology of non-Hodgkin lymphoma (NHL), a heterogeneous disease, and because dietary factors are modifiable, the authors examined the associations between nutrients related to one-carbon metabolism and risk of NHL in a population-based case-control study of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics